Transarterial chemoembolization with insertion of radioactive seeds for hepatocellular carcinoma

Bibliographic Details
Published in:	Videosurgery and Other Miniinvasive Techniques
Main Authors:	You-Bin Wang, Wei Zhang, Le Bao, Yun Lu, Jiao Hong
Format:	Article
Language:	English
Published:	Medycyna Praktyczna 2023-09-01
Subjects:	hepatocellular carcinoma brachytherapy transarterial chemoembolization
Online Access:	https://www.termedia.pl/Transarterial-chemoembolization-with-insertion-of-radioactive-seeds-for-hepatocellular-carcinoma,42,51497,1,1.html

Similar Items

Radiological response in Saudi patients undergoing transarterial chemoembolization for hepatocellular carcinoma
by: Al Fuhaid Turki, et al.
Published: (2007-01-01)

Role of drug-eluting beads versus conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Mahmoud Abu Elfadl, et al.
Published: (2019-01-01)

Laparoscopic closure of gastrohepatic fistula complicated by transarterial chemoembolization for hepatocellular carcinoma
by: Wei-Yi Liu, et al.
Published: (2024-10-01)

Long-term efficacy of transarterial chemoembolization in the treatment of recurrent hepatocellular carcinoma
by: Chao Chen, et al.
Published: (2025-09-01)

Transarterial chemoembolization in hepatocellular carcinoma treatment during the COVID-19 pandemic
by: Filipović Aleksandar, et al.
Published: (2024-01-01)

Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma
by: Zhang W, et al.
Published: (2021-07-01)

Development and Validation of a Nomogram for Patients Undergoing Transarterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy
by: Xie D, et al.
Published: (2024-04-01)

Transarterial radioembolization versus chemoembolization for hepatocellular carcinoma: a meta-analysis
by: Wenxiao Lu, et al.
Published: (2025-01-01)

Efficacy And Safety Of Raltitrexed Plus Oxaliplatin-Based Transarterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma
by: Shao W, et al.
Published: (2019-11-01)

Outcome of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
by: Hadeel A Helmi, et al.
Published: (2020-01-01)

Transarterial chemoembolization with 125I seed insertion for unresectable hepatocellular carcinoma: a meta‑analysis
by: Rui Zhu, et al.
Published: (2025-03-01)

Efficacy of Transarterial Chemoembolization (TACE) for Early-Stage Hepatocellular Carcinoma
by: Moonhyung Lee, et al.
Published: (2023-12-01)

TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma
by: Wang W, et al.
Published: (2025-01-01)

Obstructive Jaundice Following Transarterial Chemoembolization for Hepatocellular Carcinoma with Bile Duct Invasion
by: Kazuki Matsushita, et al.
Published: (2021-06-01)

Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma with Child-Pugh B7
by: Jiang JQ, et al.
Published: (2023-09-01)

Regorafenib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: a real-world study
by: Yue Han, et al.
Published: (2021-10-01)

Multicenter Study on Transarterial Chemoembolization Combined with Radiofrequency Ablation for Early-Stage Hepatocellular Carcinoma: Primary versus Recurrent HCC
by: Chen YT, et al.
Published: (2024-12-01)

Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate‐stage Hepatocellular Carcinoma: A Multicenter Retrospective Study
by: Zheng Y, et al.
Published: (2024-06-01)

Regorafenib-loaded poly (lactide-co-glycolide) microspheres designed to improve transarterial chemoembolization therapy for hepatocellular carcinoma
by: Xiang Li, et al.
Published: (2020-11-01)

Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review
by: Rahmad Mulyadi, et al.
Published: (2024-05-01)

Adjuvant Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma After Hepatectomy
by: Yue-Lin Zhang, et al.
Published: (2020-09-01)

Transarterial Chemoembolization With or Without Systemic Therapy for Unresectable Hepatocellular Carcinoma: A Retrospective Comparative Study
by: Chengxiang Guo, et al.
Published: (2025-02-01)

Transarterial Chemoembolization-induced Tumor Lysis Syndrome: Different Results in the Same Hepatocellular Carcinoma Patient
by: Hsaing-Hung Lin, et al.
Published: (2014-09-01)

Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
by: Jun Young Kim, et al.
Published: (2016-06-01)

Hypoxia as a Target for Combination with Transarterial Chemoembolization in Hepatocellular Carcinoma
by: Zizhuo Wang, et al.
Published: (2024-08-01)

Transarterial chemoembolization for hepatocellular carcinoma: Treatment algorithm proposed by Chinese College of Interventionalists (CCI)
by: Hai-Dong Zhu, et al.
Published: (2024-12-01)

Prediction model of no-response before the first transarterial chemoembolization for hepatocellular carcinoma: TACF score
by: Jia-Wei Zhong, et al.
Published: (2023-10-01)

Long‐Term Survival and Prognostic Factors of Stereotactic Body Radiotherapy Following Transarterial Chemoembolization for Hepatocellular Carcinoma
by: Hoang Dong Duc, et al.
Published: (2025-05-01)

Multi-algorithms analysis for pre-treatment prediction of response to transarterial chemoembolization in hepatocellular carcinoma on multiphase MRI
by: Mingzhen Chen, et al.
Published: (2023-02-01)

Impact of pre-sarcopenia on outcomes of transarterial chemoembolization in unresectable hepatocellular carcinoma
by: Attapon Rattanasupar, et al.
Published: (2024-08-01)

A refined prediction model for survival in hepatocellular carcinoma patients treated with transarterial chemoembolization
by: Hae Lim Lee, et al.
Published: (2024-03-01)

Hepatic arterial infusion chemotherapy versus transarterial chemoembolization for unresectable hepatocellular carcinoma: A systematic review with meta-analysis
by: Tengfei Si, et al.
Published: (2022-09-01)

Development and validation of a prealbumin–bilirubin model for prognostic prediction in intermediate hepatocellular carcinoma undergoing transarterial chemoembolization
by: Nan Jiang, et al.
Published: (2025-05-01)

Efficacy of Atezolizumab Plus Bevacizumab Combined with Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Real-World Study
by: Shen X, et al.
Published: (2024-10-01)

Safety and Effectiveness of Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Aged Greater versus Less Than 80 Years
by: Zhang L, et al.
Published: (2023-11-01)

Efficacy and safety of transarterial chemoembolization combined with lenvatinib and camrelizumab in patients with BCLC-defined stage C hepatocellular carcinoma
by: Juan Wu, et al.
Published: (2023-10-01)

Conventional versus drug-eluting bead transarterial chemoembolization: A better option for treatment of unresectable hepatocellular carcinoma
by: Murtuza Razi, et al.
Published: (2021-02-01)

The impact of drug-eluting bead (vs. conventional) transarterial chemoembolization on hepatic fibrosis in treating intermediate or advanced hepatocellular carcinoma
by: Hao Li, et al.
Published: (2023-12-01)

Quantitative literature analysis on efficacy and safety of balloon-occluded transarterial chemoembolization for hepatocellular carcinoma
by: Wei Fan Sui, et al.
Published: (2025-06-01)

Role of triphasic computed tomography in prediction of response to transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma patients
by: Ahmed A.E Hassan Desoky, et al.
Published: (2019-01-01)